DUBLIN, Jan. 6, 2026 /PRNewswire/ -- Jazz Pharmaceuticals plc (Nasdaq: JAZZ) today announced positive efficacy and safety results from the Phase 3 HERIZON-GEA-01 trial evaluating Ziihera ® ...
In 2025, IonQ IONQ and Rigetti Computing RGTI gained the attention of investors tracking the rapid evolution of the quantum computing sector. Throughout the year, IonQ demonstrated accelerating ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results